Menu
Washingtoner
  • Home
  • Health
  • Technology
  • Artificial Intelligence
  • Real Estate
  • Non-profit
  • Financial
  • Business
  • Concealed Carry
Washingtoner

FreezeNit Announces Exclusive Licensing of Novel Non-Toxic Lice Treatment Technology
Washingtoner/10287890

Trending...
  • Paul Ohana - From Beverly Hills Salon Chair To Beauty Founder Celebrity Hair Expert
  • Announcing the NCIHC 2026 Language Access Champion Awardees
  • Dividend Stacker Launches Free Calendar and Alerts for High-Yield ETF Payouts
FreezeNit
Naturally-Derived OTC Gel Eliminates Lice Without Neurotoxins, Launching Spring 2025

MARBLEHEAD, Mass. - Washingtoner -- FreezeNit, a leader in innovative lice treatment solutions, is thrilled to announce the exclusive licensing of a novel over-the-counter (OTC) lice treatment gel designed to provide a safe, naturally-derived, and highly effective alternative to traditional synthetic or pesticide-based lice treatments.

Unlike conventional OTC lice treatments that rely on pesticide-based pyrethroids, which have decreasing efficacy due to lice resistance, this new technology works by a purely mechanical method of action to eliminate lice and their eggs. The patented formula is free from harsh chemicals and instead leverages natural abrasives, such as diatomaceous earth and walnut shell powder, orange oil extract, and conditioning agents to physically shred lice and nits, while being gentle on the hair and scalp.

This addition strengthens FreezeNit's growing product portfolio, reinforcing the company's mission to provide clean, effective, science-backed treatments that parents can trust.

"This is an incredibly exciting milestone for FreezeNit," said Joanna Shu, CEO of FreezeNit. "By securing exclusive rights to this novel technology, we're positioned to be on the cutting edge of first aid treatments that are gentle on kids. Traditional lice treatments have failed parents and kids, but with this gel, lice don't stand a chance."

More on Washingtoner
  • Haven Treatment Center Now In-Network Partnership with Aetna, Expanding Access to Youth Health Care
  • Applicants Sought for the Tacoma Arts Commission and the Tacoma Creates Advisory Board
  • Spokane City Council Approves Emergency Tenant Protections
  • HydroExcavation.com Relaunches With Exclusive Local Service Areas and Dedicated Hydrovac Manufacturer Directory
  • Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight

✔ Clinically Proven – was shown to be 96% effective in a clinical trial.
✔ No Resistance Issues – Unlike permethrin-based treatments, which have seen increased lice resistance, this technology works mechanically—not chemically—so lice cannot develop immunity.
✔ Patented & Protected – This novel formula and method of action is patented in the U.S., Canada, and the EU, ensuring exclusivity in the market.
✔ Class I, 510(k) Exempt – The FDA-regulated status allows for a fast-tracked market entry.

FreezeNit is actively engaging with retailers, distributors, and healthcare providers to bring this breakthrough lice treatment to families everywhere.

FreezeNit is an innovative healthcare company dedicated to revolutionizing first-aid with safe, effective, and science-backed solutions. By leveraging cutting-edge technology and natural alternatives to neurotoxins, FreezeNit provides families with fast, reliable, and pesticide-free treatments for head lice infestations.  For more information, visit www.FreezeNit.com.

Media Contact
Cathy Henry
cathy@freezenit.com
214-924-5992


Source: FreezeNit
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Spokane: SFD's 8th Annual Kids Jr Firefighter Academy
  • Tacoma Dome Unveils Salish Mural
  • French Camp Academy Releases New Video Inviting Individuals to Consider a Life of Service
  • Tacoma: Northbound I-705 Stadium Way Off-Ramp to Close at Noon Today for Emergency Repairs
  • LET US READ Documentary on Dyslexia and Literacy to Screen at TCL Chinese 6 in Hollywood
  • PeopleNTech LLC to Participate in CWS Summit North America 2026
  • Defense & Space Strategy Strengthens as New Leadership Builds on NASA Results and Expanding Multi-Orbit Opportunities for Ascent Solar Technologies
  • STS Capital Partners is pleased to announce the appointment of Barry Brown as Vice President, Business Development
  • Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
  • Tidy-Up Tacoma Teams Up with Community Partners for Citywide Cleanup Event September 19
  • Lynnwood Heating LLC Helps Homeowners Take Advantage of 2026 Heat Pump Installation Rebates
  • Tacoma: Applicants Sought for the Board of Ethics
  • Tacoma: Applicants Sought for the Landmarks Preservation Commission
  • Heritage at Manalapan Welcomes New Sales Team as Luxury Single-Family Home Community Continues to Grow
  • Mandeville Pests May Pose Serious Health Risks for Your Family
  • Tacoma: Arrest Made in 2021 Homicide
  • Share your workplace safety solutions at 2027 Applied Ergonomics Conference
  • Parents No Longer Have to Wait 3 Weeks for a Sleep Consultant: Nora Talks Tonight, Stays for 5 Days, Costs $89
  • May The Worst Team Win! Loserball Kicks Off Another NFL Season of Hilarious Mayhem
  • Black Women Living With, and Impacted by, HIV Express Gratitude, Grief, Joy, and Resilience
_catLbl0 _catLbl1

Popular on Washingtoner

  • Spokane: SPD Arrest Level III Registered Sex Offender for Failure to Register - 573
  • Popular AI planner Voiset launches version 2.0 and enters MENA at LEAP 2026 with full Arabic support - 219
  • On the Boards: Proform Builds Announce New Construction in Alki, Seattle - 158
  • Diginyze eCommerce ERP Module Creates Single Source of Truth for Enterprise Operations - 146
  • Phinge Exposes Massive AI Security Risks, Claiming Its Patented Hardware-Verified Architecture Is The Only Safeguard Against Surveillance Capitalism - 135
  • Continuous You Foundation Opens Applications For A 100-year Artist Grant - 124
  • Tacoma: Applications Now Being Accepted for a Position on the Planning Commission - 115
  • Break the Resume Mold: Career Valet Changes How Executives Hunt for Jobs - 115
  • 3ptechies Partners with Coolmuster to Give Away Data Recovery Software Licenses - 114
  • Tacoma: Hylebos Bridge Closed Today for Maintenance Work - 103

Similar on Washingtoner

  • Longevity Academy Announces J.P. Medved of Longevity Advice as Next Guest in the Longevity Leaders
  • Medcurity Introduces a Better Way for Healthcare and Its Vendors to Build Trust
  • Haven Treatment Center Now In-Network Partnership with Aetna, Expanding Access to Youth Health Care
  • French Camp Academy Releases New Video Inviting Individuals to Consider a Life of Service
  • Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
  • Mandeville Pests May Pose Serious Health Risks for Your Family
  • Parents No Longer Have to Wait 3 Weeks for a Sleep Consultant: Nora Talks Tonight, Stays for 5 Days, Costs $89
  • Black Women Living With, and Impacted by, HIV Express Gratitude, Grief, Joy, and Resilience
  • Amaris Mint® Confirms UK Availability of Swedish-Made BioBoost Daily Nutrition Range
  • Sea Tales Strengthens U.S. Leadership Team as Retail Expansion Accelerates
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute